Globus Medical (GMED) Stock Forecast & Price Target

Compare

964 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GMED Analyst Ratings

Strong Buy

11 Buy

3 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Globus

Medical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GMED Stock 12 Month Forecast

Average Price Target

$108.54

▲(12.80% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $108.54 with a high forecast of $123.00 and a low forecast of $87.00. The average price target represents a 12.80% change from the last price of $96.22.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","124":"$124","69.25":"$69.3","87.5":"$87.5","105.75":"$105.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":123,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$123.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":108.54,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$108.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$87.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,69.25,87.5,105.75,124],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.7,92.26153846153846,94.82307692307693,97.38461538461539,99.94615384615385,102.50769230769231,105.06923076923077,107.63076923076923,110.1923076923077,112.75384615384615,115.31538461538462,117.87692307692308,120.43846153846154,{"y":123,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.7,91.14923076923077,92.59846153846154,94.04769230769232,95.49692307692308,96.94615384615385,98.39538461538461,99.8446153846154,101.29384615384616,102.74307692307693,104.1923076923077,105.64153846153847,107.09076923076924,{"y":108.54,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,89.7,89.49230769230769,89.28461538461539,89.07692307692308,88.86923076923077,88.66153846153847,88.45384615384616,88.24615384615385,88.03846153846153,87.83076923076923,87.62307692307692,87.41538461538461,87.20769230769231,{"y":87,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":92.72,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.66,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.39,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.31,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$123.00

Average Price Target$108.54

Lowest Price Target$87.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Vik Chopra

Wells Fargo

$98→$104

Buy

8.09%

Upside

Reiterated

02/26/26

Globus Medical price target raised to $104 from $98 at Wells FargoGlobus Medical price target raised to $104 from $98 at Wells Fargo

Richard Newitter

Truist Financial

$105→$115

Buy

19.52%

Upside

Reiterated

02/25/26

Truist Financial Sticks to Their Buy Rating for Globus Medical (GMED)

Mathew Blackman

TD Cowen

$110→$112

Buy

16.40%

Upside

Reiterated

02/25/26

Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation

Matt Miksic

Barclays

$118→$123

Buy

27.83%

Upside

Reiterated

02/25/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (NYSE: GMED), Standard BioTools (NASDAQ: LAB) and Addus Homecare (NASDAQ: ADUS)

Caitlin Cronin

Canaccord Genuity

$112→$115

Buy

19.52%

Upside

Reiterated

02/25/26

Globus Medical price target raised to $115 from $112 at CanaccordGlobus Medical price target raised to $115 from $112 at Canaccord

Travis Steed

Bank of America Securities

$106

Buy

10.16%

Upside

Reiterated

02/25/26

Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

02/25/26

Globus Medical (GMED) Receives a Hold from BTIG

David Saxon

Needham

$114

Buy

18.48%

Upside

Reiterated

02/25/26

Buy Rating Reaffirmed on Strong Q4 Performance, Raised 2026 EPS Outlook, and Robust Spine & Robotics Growth Prospects

Patrick Wood

Morgan Stanley

$100

Buy

3.93%

Upside

Reiterated

02/25/26

Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating

Matthew O'Brien

Piper Sandler

$115

Buy

19.52%

Upside

Reiterated

02/25/26

Piper Sandler Keeps Their Buy Rating on Globus Medical (GMED)

Shagun Singh Chadha

RBC Capital

$115

Buy

19.52%

Upside

Reiterated

02/24/26

RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED)

Matthew Taylor

Jefferies

$105→$115

Buy

19.52%

Upside

Reiterated

01/08/26

Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)

Thomas Stephan

Stifel Nicolaus

$76→$90

Hold

-6.46%

Downside

Reiterated

01/08/26

Analysts Offer Insights on Healthcare Companies: Globus Medical (NYSE: GMED) and Verrica Pharmaceuticals (NASDAQ: VRCA)

Keith Hinton

Freedom Capital Markets

$87

Hold

-9.58%

Downside

Initiated

12/16/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)

David Turkaly

Citizens JMP

―

Hold

―

Reiterated

08/20/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Vik Chopra

Wells Fargo

$98→$104

Buy

8.09%

Upside

Reiterated

02/26/26

Globus Medical price target raised to $104 from $98 at Wells FargoGlobus Medical price target raised to $104 from $98 at Wells Fargo

Richard Newitter

Truist Financial

$105→$115

Buy

19.52%

Upside

Reiterated

02/25/26

Truist Financial Sticks to Their Buy Rating for Globus Medical (GMED)

Mathew Blackman

TD Cowen

$110→$112

Buy

16.40%

Upside

Reiterated

02/25/26

Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation

Matt Miksic

Barclays

$118→$123

Buy

27.83%

Upside

Reiterated

02/25/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (NYSE: GMED), Standard BioTools (NASDAQ: LAB) and Addus Homecare (NASDAQ: ADUS)

Caitlin Cronin

Canaccord Genuity

$112→$115

Buy

19.52%

Upside

Reiterated

02/25/26

Globus Medical price target raised to $115 from $112 at CanaccordGlobus Medical price target raised to $115 from $112 at Canaccord

Travis Steed

Bank of America Securities

$106

Buy

10.16%

Upside

Reiterated

02/25/26

Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

02/25/26

Globus Medical (GMED) Receives a Hold from BTIG

David Saxon

Needham

$114

Buy

18.48%

Upside

Reiterated

02/25/26

Buy Rating Reaffirmed on Strong Q4 Performance, Raised 2026 EPS Outlook, and Robust Spine & Robotics Growth Prospects

Patrick Wood

Morgan Stanley

$100

Buy

3.93%

Upside

Reiterated

02/25/26

Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating

Matthew O'Brien

Piper Sandler

$115

Buy

19.52%

Upside

Reiterated

02/25/26

Piper Sandler Keeps Their Buy Rating on Globus Medical (GMED)

Shagun Singh Chadha

RBC Capital

$115

Buy

19.52%

Upside

Reiterated

02/24/26

RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED)

Matthew Taylor

Jefferies

$105→$115

Buy

19.52%

Upside

Reiterated

01/08/26

Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)

Thomas Stephan

Stifel Nicolaus

$76→$90

Hold

-6.46%

Downside

Reiterated

01/08/26

Analysts Offer Insights on Healthcare Companies: Globus Medical (NYSE: GMED) and Verrica Pharmaceuticals (NASDAQ: VRCA)

Keith Hinton

Freedom Capital Markets

$87

Hold

-9.58%

Downside

Initiated

12/16/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)

David Turkaly

Citizens JMP

―

Hold

―

Reiterated

08/20/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

3 Months

xxx

Success Rate

15/23 ratings generated profit

Average Return

+4.55%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +4.55% per trade.

1 Year

Matt MiksicBarclays

Success Rate

21/30 ratings generated profit

Average Return

+18.36%

a rating ―

Copying Matt Miksic's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +18.36% per trade.

2 Years

xxx

Success Rate

12/12 ratings generated profit

Average Return

+41.46%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.46% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMED Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GMED has received 27 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 108.54.

Each month's total comprises the sum of three months' worth of ratings.

GMED Financial Forecast

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is $0.91 with a range of $0.68 to $1.06. The previous quarter’s EPS was $1.28. GMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Sales Forecast

Next quarter’s sales forecast for GMED is $739.74M with a range of $718.80M to $784.90M. The previous quarter’s sales results were $826.42M. GMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Stock Forecast FAQ

What is GMED’s average 12-month price target, according to analysts?

Based on analyst ratings, Globus Medical’s 12-month average price target is 108.54.

What is GMED’s upside potential, based on the analysts’ average price target?

Globus Medical has 12.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GMED a Buy, Sell or Hold?

Globus Medical has a consensus rating of Strong Buy which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.

What is Globus Medical’s price target?

The average price target for Globus Medical is 108.54. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $123.00 ,the lowest forecast is $87.00. The average price target represents 12.80% Increase from the current price of $96.22.

What do analysts say about Globus Medical?

Globus Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of GMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Globus Medical (GMED) Stock Forecast & Price Target

GMED Analyst Ratings

GMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Globus Medical

GMED Analyst Recommendation Trends

GMED Financial Forecast

GMED Earnings Forecast

GMED Sales Forecast

GMED Stock Forecast FAQ

Detailed List of Analyst Forecasts